United States
United States

Time filter

Source Type

This report studies Global Minimally Invasive Surgical Instruments Market 2016, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Medtronic PLC Aesculap, Inc Stryker Corporation Smith & Nephew PLC Ethicon Inc Abbott Laboratories, Inc Applied Medicals Conmed Corporation Zimmer Holdings, Inc KLS Martin GmbH B. Braun By types, the market can be split into Handheld Instruments Guiding Device Inflation Systems Auxiliary Instruments Cutter Instruments By Application, the market can be split into Cardiothoracic Surgery Vascular Surgery Cosmetic/Bariatric Surgery Gastrointestinal Surgery Gynecological Surgery Urological Surgery Orthopedic Surgery Others By Regions, this report covers (we can add the regions/countries as you want) North America China Europe Southeast Asia Japan India Global Minimally Invasive Surgical Instruments Market Professional Survey Report 2016 1 Industry Overview of Minimally Invasive Surgical Instruments 1.1 Definition and Specifications of Minimally Invasive Surgical Instruments 1.1.1 Definition of Minimally Invasive Surgical Instruments 1.1.2 Specifications of Minimally Invasive Surgical Instruments 1.2 Classification of Minimally Invasive Surgical Instruments 1.2.1 Handheld Instruments 1.2.2 Guiding Device 1.2.3 Inflation Systems 1.2.4 Auxiliary Instruments 1.2.5 Cutter Instruments 1.3 Applications of Minimally Invasive Surgical Instruments 1.3.1 Cardiothoracic Surgery 1.3.2 Vascular Surgery 1.3.3 Cosmetic/Bariatric Surgery 1.3.4 Gastrointestinal Surgery 1.3.5 Gynecological Surgery 1.3.6 Urological Surgery 1.3.7 Orthopedic Surgery 1.3.8 Others 1.4 Market Segment by Regions 1.4.1 North America 1.4.2 China 1.4.3 Europe 1.4.4 Southeast Asia 1.4.5 Japan 1.4.6 India 8 Major Manufacturers Analysis of Minimally Invasive Surgical Instruments 8.1 Medtronic PLC 8.1.1 Company Profile 8.1.2 Product Picture and Specifications 8.1.2.1 Type I 8.1.2.2 Type II 8.1.2.3 Type III 8.1.3 Medtronic PLC 2015 Minimally Invasive Surgical Instruments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.1.4 Medtronic PLC 2015 Minimally Invasive Surgical Instruments Business Region Distribution Analysis 8.2 Aesculap, Inc 8.2.1 Company Profile 8.2.2 Product Picture and Specifications 8.2.2.1 Type I 8.2.2.2 Type II 8.2.2.3 Type III 8.2.3 Aesculap, Inc 2015 Minimally Invasive Surgical Instruments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.2.4 Aesculap, Inc 2015 Minimally Invasive Surgical Instruments Business Region Distribution Analysis 8.3 Stryker Corporation 8.3.1 Company Profile 8.3.2 Product Picture and Specifications 8.3.2.1 Type I 8.3.2.2 Type II 8.3.2.3 Type III 8.3.3 Stryker Corporation 2015 Minimally Invasive Surgical Instruments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.3.4 Stryker Corporation 2015 Minimally Invasive Surgical Instruments Business Region Distribution Analysis 8.4 Smith & Nephew PLC 8.4.1 Company Profile 8.4.2 Product Picture and Specifications 8.4.2.1 Type I 8.4.2.2 Type II 8.4.2.3 Type III 8.4.3 Smith & Nephew PLC 2015 Minimally Invasive Surgical Instruments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.4.4 Smith & Nephew PLC 2015 Minimally Invasive Surgical Instruments Business Region Distribution Analysis 8.5 Ethicon Inc 8.5.1 Company Profile 8.5.2 Product Picture and Specifications 8.5.2.1 Type I 8.5.2.2 Type II 8.5.2.3 Type III 8.5.3 Ethicon Inc 2015 Minimally Invasive Surgical Instruments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.5.4 Ethicon Inc 2015 Minimally Invasive Surgical Instruments Business Region Distribution Analysis 8.6 Abbott Laboratories, Inc 8.6.1 Company Profile 8.6.2 Product Picture and Specifications 8.6.2.1 Type I 8.6.2.2 Type II 8.6.2.3 Type III 8.6.3 Abbott Laboratories, Inc 2015 Minimally Invasive Surgical Instruments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.6.4 Abbott Laboratories, Inc 2015 Minimally Invasive Surgical Instruments Business Region Distribution Analysis 8.7 Applied Medicals 8.7.1 Company Profile 8.7.2 Product Picture and Specifications 8.7.2.1 Type I 8.7.2.2 Type II 8.7.2.3 Type III 8.7.3 Applied Medicals 2015 Minimally Invasive Surgical Instruments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.7.4 Applied Medicals 2015 Minimally Invasive Surgical Instruments Business Region Distribution Analysis 8.8 Conmed Corporation 8.8.1 Company Profile 8.8.2 Product Picture and Specifications 8.8.2.1 Type I 8.8.2.2 Type II 8.8.2.3 Type III 8.8.3 Conmed Corporation 2015 Minimally Invasive Surgical Instruments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.8.4 Conmed Corporation 2015 Minimally Invasive Surgical Instruments Business Region Distribution Analysis 8.9 Zimmer Holdings, Inc 8.9.1 Company Profile 8.9.2 Product Picture and Specifications 8.9.2.1 Type I 8.9.2.2 Type II 8.9.2.3 Type III 8.9.3 Zimmer Holdings, Inc 2015 Minimally Invasive Surgical Instruments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.9.4 Zimmer Holdings, Inc 2015 Minimally Invasive Surgical Instruments Business Region Distribution Analysis 8.10 KLS Martin GmbH 8.10.1 Company Profile 8.10.2 Product Picture and Specifications 8.10.2.1 Type I 8.10.2.2 Type II 8.10.2.3 Type III 8.10.3 KLS Martin GmbH 2015 Minimally Invasive Surgical Instruments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.10.4 KLS Martin GmbH 2015 Minimally Invasive Surgical Instruments Business Region Distribution Analysis 8.11 B. Braun 8.11.1 Company Profile 8.11.2 Product Picture and Specifications 8.11.2.1 Type I 8.11.2.2 Type II 8.11.2.3 Type III 8.11.3 B. Braun 2015 Minimally Invasive Surgical Instruments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.11.4 B. Braun 2015 Minimally Invasive Surgical Instruments Business Region Distribution Analysis Global QYResearch (http://globalqyresearch.com/ ) is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.


According to Stratistics MRC, the Global Minimally Invasive Surgical Instruments market is expected to grow from $9.34 billion in 2015 to reach $21.23 billion by 2022 with a CAGR of 12.4%. Better performance of minimally invasive surgeries as compared to traditional open surgeries is the main driving factor fueling the market growth. Moreover, rising chronic disorders as well surgeries and innovative technological improvements are the factors boosting the market growth. On the other hand, lack of skilled surgeons to adopt new technologies and unstable regulations in the medical industries are restricting the market growth. Access the complete report at: http://www.strategymrc.com/report/minimally-invasive-surgical-instruments-market The orthopedic surgery segment leads the market globally with the biggest market share and is expected to grow with a high CAGR during the forecast period. The growth of this segment is attributed to increasing geriatric population coupled with bone disorders and rising spine injuries. Among all product types, the handheld instruments segment dominates the global market. This is due to vast usage of the handheld instrument in most of all minimally invasive surgeries. North America is leading the global market with a higher CAGR. Asia Pacific is projected to grow at a faster pace during the forecast period. Increasing government spending, growing numerous surgeries, increasing adoption of latest surgical instruments are the factors contributing to the North America market growth. Some of the key players in global minimally invasive surgical instruments market include Davol, Inc., Conmed Corporation, Aesculap, Inc. (Subsidiary of B. Braun Melsungen AG), Aesculap, Inc., Ethicon Endo-Surgery, Inc., Encision, Inc., Acmi Circon, Abbott Laboratories , Ethicon, Inc. (Subsidiary of Johnson & Johnson), Karl Storz Endoscopy-American, Inc., Smith & Nephew PLC, Olympus Corp. of America, Microline Surgicals, Inc. (Subsidiary of Hoya Corporation), Zimmer Biomet Holdings, Inc., Stryker Corporation, and Medtronic PLC. Request for a sample at: http://www.strategymrc.com/report/minimally-invasive-surgical-instruments-market Products Covered: • Cutter Instruments o Rasps o Trocars o Other Cutter Instruments • Inflation Systems o Balloon Inflation Devices o Balloons o Other Inflation Systems • Auxiliary Instruments o Cannulas o Clamps o Closure Devices o Staplers • Handheld Instruments o Dilators o Forceps and Spatulas o Graspers o Retractors o Stents o Sutures o Visualizing scopes o Other Products • Electrosurgical Instruments o Electrocautery Devices o Electrosurgical Generators o Electrosurgical Instruments • Guiding Devices o Guidewires o Guiding Catheters End Users Covered: • Academic and Research Institutes • Government Hospitals • Private Hospitals and Surgical Clinics Applications Covered: • Gastrointestinal surgery • Cosmetic/Bariatric Surgery • Cardiothoracic Surgery • Vascular Surgery • Urological Surgery • Orthopedic Surgery • Gynecological Surgery • Other Applications o ENT/Respiratory Surgery o Neurological Surgery o Dental Surgery o Pediatric Surgery Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK  o Spain      o Rest of Europe  • Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements


Global Surgical Robots Market Forecast to 2024 – New report by Data Bridge Market Research Global Surgical Robots Market, by Product (Robotic Systems, Instruments and Accessories, Service), by Brands (Da Vinci Surgical System, Cyberknife, Renaissance, Flex, Artas, Rosa and Others), by Application (General Surgery, Urological, Gynaecological, Gastrointestinal, Radical Prostatectomy, Cardiothoracic Surgery, Colorectal Surgery, Radiotherapy and Others), by Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) - Industry Trends and Forecast to 2024. Dallas, TX, February 16, 2017 --( The global surgical robots market is segmented on the basis of product, brands, application and by geography. On the basis of product the surgical robots market is segmented into systems, instruments and accessories and service. On the basis of the brands the surgical robots market is segmented into Da Vinci Surgical system, Renaissance, Flex, Cyberknife, Artas, Rosa and others. Based on application the surgical robots market is segmented into general surgery, urological, gynecological, gastrointestinal, radiotherapy, radical prostatectomy, cardiothoracic surgery, Colon and rectal surgery and others. Request for sample pages: https://databridgemarketresearch.com/reports/surgical-robots-market-industry-trends-forecast-2024/ Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The report of this market covers data for countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa. Read more: https://databridgemarketresearch.com/reports/surgical-robots-market-industry-trends-forecast-2024/ The key players operating in this market are Intuitive Surgical, Inc., Verb Surgical Inc., Auris Surgical Robots, MedRobots Corporation, Restoration Robots, Inc., Virtual Incision Corporation, Think Surgical, Inc., Medtech Global, TransEnterix, Titan Medical Inc, Stryker, Accuray Inc., MAZOR Robots, Hansen Medical, Capsa Healthcare, LLC, Aesynt Inc, iRobot Corporation, ReWalk Robots, and Hocoma AG among others. About Data Bridge Market Research: Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Dallas, TX, February 16, 2017 --( PR.com )-- Global Surgical Robots market is expected to reach USD 14.5 billion by 2024 from USD 5.2 billion in 2016, at a CAGR of 13.7% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.The global surgical robots market is segmented on the basis of product, brands, application and by geography.On the basis of product the surgical robots market is segmented into systems, instruments and accessories and service.On the basis of the brands the surgical robots market is segmented into Da Vinci Surgical system, Renaissance, Flex, Cyberknife, Artas, Rosa and others.Based on application the surgical robots market is segmented into general surgery, urological, gynecological, gastrointestinal, radiotherapy, radical prostatectomy, cardiothoracic surgery, Colon and rectal surgery and others.Request for sample pages: https://databridgemarketresearch.com/reports/surgical-robots-market-industry-trends-forecast-2024/Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The report of this market covers data for countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa.Read more: https://databridgemarketresearch.com/reports/surgical-robots-market-industry-trends-forecast-2024/The key players operating in this market are Intuitive Surgical, Inc., Verb Surgical Inc., Auris Surgical Robots, MedRobots Corporation, Restoration Robots, Inc., Virtual Incision Corporation, Think Surgical, Inc., Medtech Global, TransEnterix, Titan Medical Inc, Stryker, Accuray Inc., MAZOR Robots, Hansen Medical, Capsa Healthcare, LLC, Aesynt Inc, iRobot Corporation, ReWalk Robots, and Hocoma AG among others.About Data Bridge Market Research:Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.


News Article | October 29, 2016
Site: www.prweb.com

Sonoma Magazine’s Top Doctor survey was submitted to Sonoma County doctors who were then asked which medical specialist they would most often recommend to a loved one, and 327 professionals emerged as top docs in 50 categories of medicine. Among physician peers Dr. Babajanian, Dr. Coleman, Dr. Dunlap and Dr. Korver ranked at the top for cardiology specialists, supporting what the many patients who routinely benefit from the expertise and outstanding cardiovascular services provided by these exemplary physicians already know. The NCMA Cardiovascular Services including Dr. Babajanian, Dr. Coleman, Dr. Dunlap and Dr. Korver is comprised of highly skilled physicians, specialists, nurses and other healthcare professionals dedicated to providing patients’ health care needs. Since 1975, the group has focused on sub-specialization within cardiovascular health to provide services by the most highly trained and experienced physicians and staff. Dr. Masis Babajanian is a fellowship trained cardiologist specializing in Cardiovascular Disease, Internal Medicine, Invasive Cardiology, Nuclear Cardiology and Pacemaker Implants. He received his medical degree from Stanford University School of Medicine and received his fellowship in cardiology from Tulane University School of Medicine, Department of Internal Medicine. Dr. Patrick Coleman is a board certified cardiologist with fellowship training in nuclear and interventional cardiology. He serves as the Medical Director of the Cardiac Catheterization Laboratories for both SRMH and Sutter Santa Rosa, as well as the Director of the Cardiology Section at NCMA. In addition to practicing cardiology at NCMA’s Santa Rosa and Ukiah offices, Dr. Coleman regularly gives lectures to the general public and health providers about maintaining and improving heart health and emergency response. Dr. Thomas Dunlap is a fellowship trained cardiologist specializing in Cardiovascular Disease, Peripheral Vascular, Endovascular Medicine, Interventional Cardiology and Pacemaker Implants. He is the Regional Director of Cardiac and Vascular Services at Santa Rosa Memorial Hospital and Director of the Cardiology Division of NCMA, and Chairman of the Endovascular Committee of Sutter Medical Center of Santa Rosa. He is published in numerous medical journals on cardiovascular health. Dr. Keith Korver is a fellowship trained Cardiothoracic Surgeon from UCSF School of Medicine as well as Pediatric Cardiac Surgery and Cardiac Transplant Surgery. He specializes in general and Cardiothoracic Surgery. NCMA Cardiology is comprised of a team of cardiologists and one cardiothoracic and vascular surgeon —all board-certified in their fields. NCMA’s HeartWorks Cardiac Rehabilitation Center provides each patient with a personal diet and exercise plan supervised by a team of physicians, nurses, and cardiac exercise specialists. In accordance with its practice of providing comprehensive cardiovascular health care, NCMA offers comprehensive care in areas including; NCMA’s services offers cardiac care in three counties, with 11 offices, located in Santa Rosa, Petaluma, Sonoma, Healdsburg, Fort Bragg, Mendocino, Gualala, Ukiah, and Lakeport. To learn more about NCMA Cardiology visit http://www.ncmahealth.com.


Willemink M.J.,University Utrecht | Leiner T.,University Utrecht | De Jong P.A.,University Utrecht | De Heer L.M.,Cardiothoracic Surgery | And 4 more authors.
European Radiology | Year: 2013

Objectives: To present the results of a systematic literature search aimed at determining to what extent the radiation dose can be reduced with iterative reconstruction (IR) for cardiopulmonary and body imaging with computed tomography (CT) in the clinical setting and what the effects on image quality are with IR versus filtered back-projection (FBP) and to provide recommendations for future research on IR. Methods: We searched Medline and Embase from January 2006 to January 2012 and included original research papers concerning IR for CT. Results: The systematic search yielded 380 articles. Forty-nine relevant studies were included. These studies concerned: the chest(n = 26), abdomen(n = 16), both chest and abdomen(n = 1), head(n = 4), spine(n = 1), and no specific area (n = 1). IR reduced noise and artefacts, and it improved subjective and objective image quality compared to FBP at the same dose. Conversely, low-dose IR and normal-dose FBP showed similar noise, artefacts, and subjective and objective image quality. Reported dose reductions ranged from 23 to 76 % compared to locally used default FBP settings. However, IR has not yet been investigated for ultra-low-dose acquisitions with clinical diagnosis and accuracy as endpoints. Conclusion: Benefits of IR include improved subjective and objective image quality as well as radiation dose reduction while preserving image quality. Future studies need to address the value of IR in ultra-low-dose CT with clinically relevant endpoints. Key Points: • Iterative reconstruction improves image quality of CT images at equal acquisition parameters. • IR preserves image quality compared to normal-dose filtered back-projection. • The reduced radiation dose made possible by IR is advantageous for patients. • IR has not yet been investigated with clinical diagnosis and accuracy as endpoints. © 2013 European Society of Radiology.


Bishawi M.,Cardiothoracic Surgery | Moore W.,Radiology | Bilfinger T.,Cardiothoracic Surgery
Journal of Surgical Research | Year: 2013

Background: Nonesmall cell lung cancer (NSCLC) has a predilection to occur in emphysematous lungs. The relation between the regional severity of emphysema and the location of NSCLC as well as long-term survival has been poorly studied. Methods: Computed tomography (CT) scans of 153 patients with biopsy-proven stage I NSCLC diagnosed between 2001 and 2006 were assigned an emphysema severity score in four regions of the lung. The location of the cancer was compared with the severity of emphysema in that region. Survival was also analyzed. Results: Thirty-nine patients had no emphysema documented on CT scan and 114 did. The most common location of cancer was the right upper quadrant with 37% of cancers, followed by the left upper quadrant with 23% of cancers. Twenty-two percent of the cancers occurred in the right lower quadrant, and only 12% were in the left lower quadrant. There is a strong association for cancer being located in the area with the highest degree of emphysema (P < 0.001). Emphysema severity score was also associated with long-term survival (log-rank P = 0.03). Conclusions: The regional severity of emphysema assessed via a visual scale using CT appears to be associated with the location of lung cancer and is an independent predictor of long-term survival. © 2013 Elsevier Inc. All rights reserved.


Pasquali S.K.,Duke University | Pasquali S.K.,Duke Clinical Research Institute | Sun J.-L.,Duke University | Sun J.-L.,Duke Clinical Research Institute | And 7 more authors.
Circulation: Cardiovascular Quality and Outcomes | Year: 2011

Background: Congenital heart disease consumes significant health care resources; however, there are limited data regarding factors affecting resource utilizationThe purpose of this study was to evaluate variation between centers in total hospital costs for 4 congenital heart operations of varying complexity and associated factorsMethods and Results: The Premier Database was used to evaluate total cost in children undergoing isolated atrial septal defect (ASD) repair, ventricular septal defect (VSD) repair, tetralogy of Fallot (TOF) repair, or arterial switch operation (ASO) from 2001 to 2007Mixed models were used to evaluate the impact of center on total hospital costs adjusting for patient and center characteristics and length of stayA total of 2124 patients were included: 719 ASD (19 centers), 792 VSD (20 centers), 420 TOF (17 centers), and 193 ASO (13 centers)Total cost increased with complexity of operation from median $12 761 (ASD repair) to $55 430 (ASO)In multivariable analysis, models that accounted for center effects versus those that did not performed significantly better for all 4 surgeries (all P≤0.01)The proportion of total cost variation explained by center was 19% (ASD repair), 11% (VSD repair), 6% (TOF repair), and 3% (ASO)Higher-volume centers had significantly lower hospital costs for ASD and VSD repair but not for TOF repair and ASOConclusions: Total hospital costs varied significantly by center for all congenital heart surgeries evaluated, even after adjustment for patient and center characteristics and length of stayDifferences among centers were most prominent for lower complexity procedures. © 2011 American Heart Association, Inc.


Taramasso M.,San Raffaele Scientific Institute | Vanermen H.,Cardiothoracic Surgery | Maisano F.,San Raffaele Scientific Institute | Guidotti A.,San Raffaele Scientific Institute | And 2 more authors.
Journal of the American College of Cardiology | Year: 2012

Functional or secondary tricuspid regurgitation (STR) is the most frequent etiology of tricuspid valve pathology in Western countries. Surgical tricuspid repair has been avoided for years, because of the misconception that tricuspid regurgitation should disappear once the primary left-sided problem is treated; this results in a large number of untreated patients with STR. Over the past few years, many investigators have reported evidence in favor of a more aggressive surgical approach to STR. Consequently, interest has been growing in the physiopathology and treatment of STR. The purpose of this review is to explore the anatomical basis, pathophysiology, therapeutic approach, and future perspectives with regard to the management of STR. © 2012 American College of Cardiology Foundation.


The International Association of HealthCare Professionals is pleased to welcome Zain Khalpey, MD, PhD, FACS, FETC, cardiothoracic surgeon, to their prestigious organization with his upcoming publication in The Leading Physicians of the World. He is a highly-trained and qualified cardiothoracic surgeon with expertise in all facets of his work. Dr. Zain Khalpey has been practicing for more than 18 years and is currently working at Arizona University Medical Center in Tucson, Arizona. He is also affiliated to Banner – University Medical Center. Dr. Zain Khalpey obtained his Doctor of Medicine degree at Guy’s, King’s & St. Thomas School of Medicine at the University of London in England in 1998. After moving to the United States, Dr. Khalpey completed a cardiac surgery internship at Brigham and Women’s Hospital prior to a residency was completed at Columbia University. Dr. Khalpey is certified by the American Board of Thoracic Surgery – Cardiac Surgery, and by the European Board of Cardiothoracic Surgery. He is internationally renowned as an expert in pediatric and adult heart transplantation, and remains a member of the American Association for Thoracic Surgery, the Society of Thoracic Surgeons, and the American Academy and Board of Regenerative Medicine. Dr. Khalpey has also earned the coveted title of Fellow of the American College of Surgeons, and he says that his success is due to his persistence and his passion for knowledge. Learn more about Dr. Khalpey by reading his upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics.  Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review.  FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise.  A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life.  For more information about FindaTopDoc, visit: http://www.findatopdoc.com


The International Association of HealthCare Professionals is pleased to welcome Stephen Andrew Chung, MD, Anesthesiologist, to their prestigious organization with his upcoming publication in The Leading Physicians of the World. Dr. Chung is a highly trained and qualified anesthesiologist with a vast expertise in all facets of his work. Dr. Chung has been in practice for more than 27 years and is currently serving patients at Valley Anesthesiology and Pain Consultants in Phoenix, Arizona. The center is one of the nation’s premier providers of anesthesia and pain management services, ensuring that their patients receive exceptional perioperative anesthesia care. Furthermore, Dr. Chung is affiliated with Scottsdale Healthcare and Banner Healthcare Network. Dr. Chung’s career in medicine began in 1987 when he graduated with his Medical Degree from the University of Calgary Faculty of Medicine. Following his graduation, Dr. Chung subsequently completed his internship at North York General Hospital, followed by his Cardiothoracic Surgery fellowship at the University of Toronto. Dr. Chung holds board certification in Anesthesiology, and keeps up to date with the latest advances and developments in his field through his professional membership with the American Society of Anesthesiologists, the Arizona Society of Anesthesiologists, and the Canadian Medical Association. He attributes his success to his good training, being flexible, and staying on top of the changes in medicine. When he is not assisting patients, Dr. Chung enjoys skiing, running, cooking, and watching college football. Learn more about Dr. Chung by reading his upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics.  Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review.  FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise.  A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life.  For more information about FindaTopDoc, visit:http://www.findatopdoc.com

Loading Cardiothoracic Surgery collaborators
Loading Cardiothoracic Surgery collaborators